Cancer prevention research
that doesn't insult your intelligence.
We analyze clinical trials, meta-analyses, and emerging evidence on cancer prevention and repurposed treatments. Every claim gets an evidence grade. No supplements to sell. No miracle cures. Just research.
Our Evidence Grading System
Every compound and intervention gets a grade based on the quality of human clinical evidence, not animal studies or test tubes.
Latest Research
Mebendazole for Lung Cancer
Phase I/II data in small cell lung cancer. Microtubule disruption mechanism, crosses blood-brain barrier.
🔬 Grade B: PromisingItraconazole for Lung Cancer
Phase II trial in NSCLC showing 72-79% tumor growth reduction in xenograft models. Hedgehog + VEGFR2 pathway inhibition.
🔬 Grade B: PromisingDisulfiram (Antabuse) + Copper for Cancer
Phase II trials in GBM, breast, and pancreatic cancer. Cuproptosis mechanism discovered in 2022. Cancer stem cell elimination.
🔬 Grade B: PromisingThe Press-Pulse Protocol
Thomas Seyfried's metabolic framework targets both glucose and glutamine simultaneously. The most complete dietary-metabolic approach to cancer management.
🔬 Grade B: PromisingThe Galleri Test: Is $950/yr Worth It?
A blood test that detects 50 cancer types. PATHFINDER 2 trial showed 7x cancer detection. We analyze what that actually means.
⭐ Grade A: Strong EvidenceHigh-Dose Melatonin: The 34% Mortality Reduction
Meta-analysis of 8 RCTs shows melatonin at 10-20mg reduced cancer mortality by 34%. No toxicity ever established.
🔬 Grade B: PromisingNew research reviews every month.
We track clinical trials, emerging compounds, and AI-driven cancer discoveries. Get updates when we publish new evidence reviews.